Gepotidacin Mesylate Dihydrate is a first-in-class triazaacenaphthylene antibacterial agent designed to inhibit bacterial DNA gyrase and topoisomerase IV, effectively blocking bacterial DNA replication.… Read more
Gepotidacin Mesylate Dihydrate is a first-in-class triazaacenaphthylene antibacterial agent designed to inhibit bacterial DNA gyrase and topoisomerase IV, effectively blocking bacterial DNA replication. This medication is indicated for treating complicated intra-abdominal infections caused by specific pathogens such as Escherichia coli and Klebsiella pneumoniae. Laboratories utilize high-quality reference standards of the active pharmaceutical ingredient, along with its related impurities and metabolites, to conduct robust analytical testing and rigorous quality control. These materials are essential for method validation, including the identification and quantification of process-related impurities and degradation products. Furthermore, stable isotope-labelled compounds of Gepotidacin Mesylate Dihydrate are frequently employed in mass spectrometry-based assays as internal standards to ensure accuracy and precision during impurity profiling and pharmacokinetic studies. By maintaining access to these specialized reference materials, analytical chemists can reliably monitor drug purity and safety throughout the pharmaceutical development and manufacturing process.